Diep Tuan Tu has filed 21 insider transactions across 1 company since February 2024.
Most recent transaction: a disposition of 75000 shares of Skye Bioscience, Inc. ($SKYE) on March 31, 2026.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | D | Stock Option (Right to Buy) | 75000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.19% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 39,665,927 | 9999.99% | 0.32% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | D | Stock Option (Right to Buy) | 125000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.32% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | A | Stock Option (Right to Buy) | 8000 | $0.00 | 8,000.0000 | 39,665,927 | 9999.99% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | D | Stock Option (Right to Buy) | 8000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | A | Stock Option (Right to Buy) | 7080 | $0.00 | 7,080.0000 | 39,665,927 | 9999.99% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | D | Stock Option (Right to Buy) | 7080 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 39,665,927 | 9999.99% | 0.19% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 39,665,927 | 9999.99% | 0.38% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | D | Stock Option (Right to Buy) | 150000 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.38% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | A | Stock Option (Right to Buy) | 9194 | $0.00 | 9,194.0000 | 39,665,927 | 9999.99% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | D | Stock Option (Right to Buy) | 9194 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.02% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | A | Stock Option (Right to Buy) | 22021 | $0.00 | 22,021.0000 | 39,665,927 | 9999.99% | 0.06% |
| March 31, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Operating Officer | D | Stock Option (Right to Buy) | 22021 | $0.00 | 0.0000 | 39,665,927 | 100.00% | 0.06% |
| Feb. 6, 2026 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Development Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 39,665,927 | 9999.99% | 0.32% |
| Feb. 24, 2025 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Development Officer | A | Stock Option (Right to Buy) | 150000 | $0.00 | 150,000.0000 | 36,486,519 | 9999.99% | 0.41% |
| Nov. 15, 2024 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Development Officer | S | Common Stock | 85 | $5.55 | 101,748.0000 | 38,819,387 | 0.08% | 0.00% |
| Nov. 18, 2024 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Development Officer | S | Common Stock | 19489 | $4.99 | 82,259.0000 | 38,819,387 | 19.15% | 0.05% |
| Oct. 28, 2024 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Development Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 38,819,387 | 9999.99% | 0.32% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Development Officer | A | Common Stock | 25000 | $0.00 | 101,833.0000 | 7,006,038 | 32.54% | 0.36% |
| Feb. 29, 2024 | Skye Bioscience, Inc. | $SKYE | Diep Tuan Tu | Chief Development Officer | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 7,006,038 | 9999.99% | 1.07% |